Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_assertion type Assertion NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_head.
- NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_assertion description "[For women, subjects featuring the CYP1A1*2C G/G genotype and the XRCC3 Thr/Thr genotype faced a 3.1-fold greater risk (95% CI = 1.3-7.0) of colorectal cancer when compared to those featuring the CYP1A1*2C A allele and the XRCC3 Met allele.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_provenance.
- NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_assertion evidence source_evidence_literature NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_provenance.
- NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_assertion SIO_000772 17191090 NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_provenance.
- NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_assertion wasDerivedFrom gad-20150221 NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_provenance.
- NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_assertion wasGeneratedBy ECO_0000203 NP86397.RAVKVgsCcbS6-Ph66i6xnicRl8-eA_sqNG_nv28geHLPE130_provenance.